KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Change in Inventory (2018 - 2025)

Rigel Pharmaceuticals (RIGL) has 8 years of Change in Inventory data on record, last reported at -$1.1 million in Q4 2025.

  • For Q4 2025, Change in Inventory rose 41.25% year-over-year to -$1.1 million; the TTM value through Dec 2025 reached $5.6 million, up 837.57%, while the annual FY2025 figure was $5.6 million, 837.57% up from the prior year.
  • Change in Inventory reached -$1.1 million in Q4 2025 per RIGL's latest filing, down from -$188000.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $8.4 million in Q2 2025 and bottomed at -$3.3 million in Q3 2024.
  • Average Change in Inventory over 5 years is $547550.0, with a median of -$151000.0 recorded in 2021.
  • Peak YoY movement for Change in Inventory: surged 2078.51% in 2021, then plummeted 1090.04% in 2024.
  • A 5-year view of Change in Inventory shows it stood at -$450000.0 in 2021, then skyrocketed by 540.67% to $2.0 million in 2022, then tumbled by 227.63% to -$2.5 million in 2023, then rose by 23.94% to -$1.9 million in 2024, then surged by 41.25% to -$1.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Inventory were -$1.1 million in Q4 2025, -$188000.0 in Q3 2025, and $8.4 million in Q2 2025.